Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01693874 · ClinicalTrials.gov registry record · Phase 1
Mindfulness-based Stress Reduction and Cognitive Function in Stress and Aging
A Phase 1 study of Depression and Anxiety Disorders, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Phase 1
- Development phase
- 103
- Enrollment target
- 2
- Study locations
NCT01693874 is a Phase 1 study of Depression and Anxiety Disorders that has completed, run by Washington University School of Medicine. The registered enrollment target is 103 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (87% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT01693874, a Phase 1 study of Depression and Anxiety Disorders, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 103 participants
- Enrollment target
- 2
- Study locations
Study Summary
The investigators are developing and then testing whether Mindfulness-Based Stress Reduction, a group-based instruction for increasing mindfulness, reduces anxiety and depressive symptoms and improves cognitive functioning in older adults.
Conditions Studied
Interventions
- BEHAVIORAL MBSR
- BEHAVIORAL control (health education)
Study Locations (2)
California
- University of California San Diego - San Diego
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 103 participants |
| Start Date | 2011-10 |
| Est. Completion | 2014-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01693874
The ClinicalTrials.gov registry entry for NCT01693874 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 103 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (87% lower). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which MBSR is the first listed.
NCT01693874 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Missouri.
Frequently Asked Questions
What is clinical trial NCT01693874 about?
NCT01693874 is a clinical study titled "Mindfulness-based Stress Reduction and Cognitive Function in Stress and Aging". The investigators are developing and then testing whether Mindfulness-Based Stress Reduction, a group-based instruction for increasing mindfulness, reduces anxiety and depressive symptoms and improves cognitive functioning in older adults.
What is the current status of trial NCT01693874?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 103 participants. The study started on 2011-10. Estimated completion is 2014-06.
What conditions does trial NCT01693874 study?
This clinical trial studies the following conditions: Depression, Anxiety Disorders.
What interventions are being tested in trial NCT01693874?
The interventions under investigation include: MBSR (BEHAVIORAL), control (health education) (BEHAVIORAL).
Who is sponsoring clinical trial NCT01693874?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01693874 being conducted?
This trial has 2 study locations across California, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
RECRUITING · Phase 1
-
PET Imaging of Cyclooxygenase in Participants With Major Depressive Disorder (MDD)
RECRUITING · Phase 1
-
Mechanism of Action Underlying Ketamine's Antidepressant Effects: The AMPA Throughput Theory in Patients With Treatment-Resistant Major Depression
RECRUITING · Phase 1
-
Study of the Safety, Tolerability, Electrophysiological Effects and Efficacy of DMT in Humans
RECRUITING · Phase 1
-
[18F]PF-06445974 to Image PDE4B in Major Depressive Disorder Using PET
RECRUITING · Phase 1
-
Feasibility and Safety of Ketamine for Suicidal Patients in the Emergency Department
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.